Fig. 11From: Effects of dapagliflozin in the progression of atherosclerosis in patients with type 2 diabetes: a meta-analysis of randomized controlled trialsImpact of dapagliflozin on HbA1c changes relative to baseline after deleting Fadini 2017 and Shigiyama 2017Back to article page